The latest cancer drugs news
Browsing: Cancer Drug News
Drug overcomes chemotherapy resistance in ovarian cancer
An international research team, led by scientists from Mater Research—The University of Queensland, have discovered…
FDA approves mitomycin for low-grade upper tract urothelial cancer
The Food and Drug Administration (FDA) approved mitomycin for adult patients with low-grade upper tract…
Drug prevents cognitive impairment in mice after radiation treatment for brain tumours
A study by researchers at the UCLA Jonsson Comprehensive Cancer Center, USA, has identified a…
Aspirin linked to reduction in risk of several cancers of the digestive tract
Aspirin is associated with a reduction in the risk of developing several cancers of the…
RNA drugs one step closer to be being used in cancer treatment
In recent years, RNA molecules, with the ability to affect or turn off pathogenic genes,…
Experimental drug offers hope for preventing cancer relapse
A drug that is well-tolerated in patients and prevents cancer coming back in mice has…
PARP inhibitor drugs can be ‘tuned’ for better killing of tumour cells
A prospective “PARP inhibitor” drug that has struggled to show effectiveness in clinical trials against…
FDA approves encorafenib in combination with cetuximab for metastatic colorectal cancer with a BRAF V600E mutation
The Food and Drug Administration (FDA) have approved encorafenib in combination with cetuximab for the…
Protected: PBS listing for BRAFTOVI® (encorafenib) + MEKTOVI® (binimetinib) combination therapy for adults with unresectable malignant BRAF-mutant melanoma [1]
This content is password-protected. To view it, please enter the password below. Password:
Tailoring an anti-cancer drug for optimal tumour cell killing
In a study published this in Science, Université de Montreal, Canada, researchers report key structural and…